Concepts (261)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Skin Diseases | 4 | 2019 | 166 | 1.940 |
Why?
|
| Skin | 9 | 2022 | 554 | 1.890 |
Why?
|
| Dermatology | 4 | 2021 | 35 | 1.510 |
Why?
|
| Acne Vulgaris | 2 | 2017 | 32 | 1.160 |
Why?
|
| Skin Pigmentation | 4 | 2021 | 40 | 1.120 |
Why?
|
| Child | 18 | 2023 | 6927 | 1.070 |
Why?
|
| Exanthema | 2 | 2023 | 36 | 1.030 |
Why?
|
| Skin Diseases, Vesiculobullous | 4 | 2015 | 18 | 1.010 |
Why?
|
| Hair | 2 | 2018 | 56 | 1.000 |
Why?
|
| Lupus Erythematosus, Cutaneous | 1 | 2023 | 5 | 0.930 |
Why?
|
| Food Addiction | 1 | 2023 | 1 | 0.930 |
Why?
|
| Depression, Postpartum | 1 | 2023 | 14 | 0.910 |
Why?
|
| Dermatitis | 1 | 2023 | 32 | 0.910 |
Why?
|
| Hidradenitis Suppurativa | 1 | 2023 | 11 | 0.900 |
Why?
|
| Autoimmune Diseases | 2 | 2023 | 241 | 0.870 |
Why?
|
| Granuloma Annulare | 1 | 2022 | 2 | 0.860 |
Why?
|
| Spider Bites | 1 | 2021 | 2 | 0.840 |
Why?
|
| Vaccines | 2 | 2014 | 80 | 0.830 |
Why?
|
| Internship and Residency | 2 | 2021 | 1004 | 0.830 |
Why?
|
| Infant | 11 | 2023 | 3046 | 0.830 |
Why?
|
| Lichen Nitidus | 1 | 2021 | 1 | 0.820 |
Why?
|
| Papilloma | 1 | 2021 | 22 | 0.820 |
Why?
|
| Hypopigmentation | 1 | 2021 | 4 | 0.820 |
Why?
|
| Herpes Zoster | 1 | 2022 | 78 | 0.810 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2023 | 206 | 0.800 |
Why?
|
| Humans | 49 | 2023 | 86643 | 0.790 |
Why?
|
| Fingers | 1 | 2021 | 68 | 0.790 |
Why?
|
| Panniculitis | 2 | 2011 | 8 | 0.770 |
Why?
|
| Abnormalities, Multiple | 6 | 2022 | 232 | 0.760 |
Why?
|
| Siblings | 2 | 2019 | 111 | 0.710 |
Why?
|
| Xeroderma Pigmentosum Group D Protein | 1 | 2019 | 4 | 0.710 |
Why?
|
| Trichothiodystrophy Syndromes | 1 | 2019 | 4 | 0.710 |
Why?
|
| Calcineurin Inhibitors | 2 | 2018 | 54 | 0.700 |
Why?
|
| Dermatitis, Atopic | 3 | 2016 | 52 | 0.680 |
Why?
|
| Alopecia Areata | 1 | 2018 | 4 | 0.650 |
Why?
|
| Hydroxychloroquine | 1 | 2018 | 10 | 0.650 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2018 | 19 | 0.630 |
Why?
|
| Infant, Newborn | 8 | 2023 | 2379 | 0.630 |
Why?
|
| Molluscum Contagiosum | 1 | 2017 | 1 | 0.620 |
Why?
|
| Hypersensitivity | 1 | 2019 | 154 | 0.610 |
Why?
|
| Skin Neoplasms | 1 | 2021 | 546 | 0.580 |
Why?
|
| Vascular Malformations | 2 | 2016 | 19 | 0.580 |
Why?
|
| Skin Diseases, Vascular | 1 | 2016 | 3 | 0.570 |
Why?
|
| Lymphatic Diseases | 1 | 2016 | 37 | 0.560 |
Why?
|
| Pandemics | 2 | 2022 | 740 | 0.560 |
Why?
|
| Ice | 1 | 2015 | 11 | 0.550 |
Why?
|
| Frostbite | 1 | 2015 | 8 | 0.550 |
Why?
|
| Child, Preschool | 10 | 2022 | 3612 | 0.550 |
Why?
|
| Cryotherapy | 1 | 2015 | 29 | 0.540 |
Why?
|
| Insect Bites and Stings | 1 | 2015 | 2 | 0.540 |
Why?
|
| Knee Injuries | 1 | 2015 | 53 | 0.530 |
Why?
|
| Arthroscopy | 1 | 2015 | 94 | 0.510 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 639 | 0.510 |
Why?
|
| Drug Eruptions | 1 | 2014 | 35 | 0.500 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2016 | 263 | 0.500 |
Why?
|
| Mutation | 5 | 2019 | 3968 | 0.490 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 806 | 0.480 |
Why?
|
| Male | 22 | 2023 | 40965 | 0.480 |
Why?
|
| Limb Deformities, Congenital | 2 | 2016 | 21 | 0.480 |
Why?
|
| Female | 22 | 2023 | 44532 | 0.470 |
Why?
|
| Adolescent | 10 | 2021 | 8981 | 0.460 |
Why?
|
| HIV Infections | 1 | 2022 | 772 | 0.460 |
Why?
|
| Acrodermatitis | 1 | 2013 | 3 | 0.450 |
Why?
|
| Leg Dermatoses | 1 | 2013 | 7 | 0.450 |
Why?
|
| Facial Dermatoses | 1 | 2013 | 13 | 0.450 |
Why?
|
| Netherton Syndrome | 1 | 2012 | 2 | 0.440 |
Why?
|
| Ultraviolet Therapy | 1 | 2012 | 15 | 0.430 |
Why?
|
| Aluminum Compounds | 1 | 2011 | 6 | 0.410 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2011 | 7 | 0.410 |
Why?
|
| Diagnosis, Differential | 6 | 2018 | 1565 | 0.410 |
Why?
|
| Retrospective Studies | 8 | 2023 | 8489 | 0.410 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 746 | 0.400 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2011 | 16 | 0.400 |
Why?
|
| Chlorides | 1 | 2011 | 103 | 0.390 |
Why?
|
| Loose Anagen Hair Syndrome | 1 | 2010 | 5 | 0.380 |
Why?
|
| Beauty Culture | 1 | 2010 | 1 | 0.380 |
Why?
|
| Hypothermia, Induced | 1 | 2011 | 74 | 0.380 |
Why?
|
| Facial Neoplasms | 2 | 2007 | 25 | 0.370 |
Why?
|
| Alopecia | 1 | 2010 | 34 | 0.370 |
Why?
|
| Hemangioma | 2 | 2007 | 60 | 0.360 |
Why?
|
| Microphthalmos | 1 | 2008 | 7 | 0.340 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 1036 | 0.330 |
Why?
|
| Skin Abnormalities | 1 | 2008 | 11 | 0.330 |
Why?
|
| Pachyonychia Congenita | 1 | 2007 | 1 | 0.310 |
Why?
|
| Keratin-6 | 1 | 2007 | 3 | 0.310 |
Why?
|
| Lipoma | 1 | 2006 | 25 | 0.280 |
Why?
|
| Calcinosis | 1 | 2007 | 224 | 0.260 |
Why?
|
| Maxillofacial Abnormalities | 1 | 2004 | 2 | 0.250 |
Why?
|
| Tooth Abnormalities | 1 | 2004 | 6 | 0.250 |
Why?
|
| Inflammation | 1 | 2010 | 920 | 0.250 |
Why?
|
| Facial Asymmetry | 1 | 2004 | 12 | 0.250 |
Why?
|
| Miliaria | 1 | 2004 | 1 | 0.250 |
Why?
|
| Clindamycin | 1 | 2023 | 13 | 0.230 |
Why?
|
| Syndrome | 4 | 2008 | 446 | 0.220 |
Why?
|
| Darier Disease | 1 | 2022 | 4 | 0.210 |
Why?
|
| Hyperpigmentation | 1 | 2022 | 5 | 0.210 |
Why?
|
| Postpartum Period | 1 | 2023 | 135 | 0.210 |
Why?
|
| Hair Diseases | 1 | 2022 | 9 | 0.210 |
Why?
|
| Oligopeptides | 1 | 2023 | 179 | 0.210 |
Why?
|
| Smallpox Vaccine | 2 | 2014 | 12 | 0.210 |
Why?
|
| Herpesvirus 3, Human | 1 | 2022 | 43 | 0.210 |
Why?
|
| Public Assistance | 1 | 2021 | 6 | 0.210 |
Why?
|
| Spiders | 1 | 2021 | 14 | 0.210 |
Why?
|
| Erythema | 1 | 2021 | 27 | 0.200 |
Why?
|
| Public Opinion | 1 | 2021 | 43 | 0.200 |
Why?
|
| Scleroderma, Localized | 1 | 2021 | 9 | 0.200 |
Why?
|
| Necrosis | 1 | 2021 | 204 | 0.200 |
Why?
|
| Headache Disorders | 1 | 2021 | 6 | 0.200 |
Why?
|
| Hot Temperature | 1 | 2021 | 206 | 0.190 |
Why?
|
| Musculoskeletal Diseases | 1 | 2021 | 34 | 0.190 |
Why?
|
| Face | 1 | 2021 | 114 | 0.190 |
Why?
|
| Feeding Behavior | 1 | 2023 | 324 | 0.190 |
Why?
|
| Diet | 1 | 2023 | 443 | 0.180 |
Why?
|
| Hair Color | 1 | 2019 | 8 | 0.180 |
Why?
|
| Career Choice | 1 | 2021 | 139 | 0.180 |
Why?
|
| Melanins | 1 | 2019 | 23 | 0.180 |
Why?
|
| Melanocytes | 1 | 2019 | 56 | 0.170 |
Why?
|
| Culture | 1 | 2019 | 53 | 0.170 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 484 | 0.170 |
Why?
|
| Seizures | 1 | 2021 | 297 | 0.160 |
Why?
|
| Remission, Spontaneous | 1 | 2018 | 53 | 0.160 |
Why?
|
| Comorbidity | 1 | 2022 | 943 | 0.160 |
Why?
|
| Lichen Sclerosus et Atrophicus | 1 | 2018 | 7 | 0.160 |
Why?
|
| Vitiligo | 1 | 2018 | 15 | 0.160 |
Why?
|
| Curriculum | 1 | 2021 | 539 | 0.150 |
Why?
|
| Gestational Age | 1 | 2018 | 311 | 0.150 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1805 | 0.150 |
Why?
|
| Anodontia | 1 | 2016 | 1 | 0.150 |
Why?
|
| Ectodermal Dysplasia | 1 | 2016 | 2 | 0.150 |
Why?
|
| Lacrimal Duct Obstruction | 1 | 2016 | 3 | 0.150 |
Why?
|
| Nails, Malformed | 1 | 2016 | 3 | 0.150 |
Why?
|
| Pigmentation Disorders | 1 | 2016 | 13 | 0.140 |
Why?
|
| Dermoscopy | 1 | 2016 | 5 | 0.140 |
Why?
|
| Ambulatory Care Facilities | 1 | 2017 | 102 | 0.140 |
Why?
|
| Pruritus | 1 | 2015 | 26 | 0.140 |
Why?
|
| Pregnancy | 1 | 2023 | 2894 | 0.140 |
Why?
|
| Siphonaptera | 1 | 2015 | 8 | 0.140 |
Why?
|
| Infant, Premature | 1 | 2018 | 290 | 0.140 |
Why?
|
| Glucocorticoids | 1 | 2018 | 352 | 0.130 |
Why?
|
| Leukemoid Reaction | 1 | 2015 | 5 | 0.130 |
Why?
|
| Biopsy, Needle | 1 | 2015 | 235 | 0.130 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 1313 | 0.130 |
Why?
|
| Risk Assessment | 3 | 2021 | 2261 | 0.130 |
Why?
|
| Down Syndrome | 1 | 2015 | 53 | 0.130 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 371 | 0.130 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 508 | 0.130 |
Why?
|
| Ichthyosis Vulgaris | 1 | 2014 | 1 | 0.130 |
Why?
|
| Intermediate Filament Proteins | 1 | 2014 | 35 | 0.120 |
Why?
|
| Disease Management | 1 | 2017 | 327 | 0.120 |
Why?
|
| Postoperative Care | 1 | 2015 | 221 | 0.120 |
Why?
|
| Breast | 1 | 2016 | 288 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 279 | 0.120 |
Why?
|
| Pedigree | 1 | 2016 | 966 | 0.120 |
Why?
|
| Buttocks | 1 | 2013 | 10 | 0.110 |
Why?
|
| Arm | 1 | 2013 | 91 | 0.110 |
Why?
|
| Patch Tests | 1 | 2011 | 4 | 0.100 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2011 | 3 | 0.100 |
Why?
|
| Hepatitis B Vaccines | 1 | 2011 | 13 | 0.100 |
Why?
|
| Pneumococcal Vaccines | 1 | 2011 | 28 | 0.100 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 1753 | 0.100 |
Why?
|
| Autoantibodies | 1 | 2012 | 267 | 0.090 |
Why?
|
| Granulation Tissue | 1 | 2010 | 15 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2016 | 2271 | 0.090 |
Why?
|
| Debridement | 1 | 2010 | 56 | 0.090 |
Why?
|
| Animals | 5 | 2021 | 26582 | 0.090 |
Why?
|
| Microscopy | 1 | 2010 | 87 | 0.090 |
Why?
|
| Scalp | 1 | 2010 | 72 | 0.090 |
Why?
|
| Maus Elberfeld virus | 4 | 1990 | 34 | 0.090 |
Why?
|
| Enterovirus | 4 | 1990 | 34 | 0.090 |
Why?
|
| Kaposi Varicelliform Eruption | 1 | 2008 | 6 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2016 | 1565 | 0.080 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 3640 | 0.080 |
Why?
|
| Chromosomes, Human, X | 1 | 2008 | 55 | 0.080 |
Why?
|
| Adipose Tissue | 1 | 2010 | 240 | 0.080 |
Why?
|
| United States | 2 | 2018 | 6672 | 0.070 |
Why?
|
| Biopsy | 1 | 2011 | 1163 | 0.070 |
Why?
|
| Sternum | 1 | 2006 | 30 | 0.070 |
Why?
|
| Dandy-Walker Syndrome | 1 | 2006 | 20 | 0.070 |
Why?
|
| Ear, External | 1 | 2007 | 26 | 0.070 |
Why?
|
| Heel | 1 | 2006 | 4 | 0.070 |
Why?
|
| Groin | 1 | 2006 | 8 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2018 | 7993 | 0.070 |
Why?
|
| Adult | 2 | 2022 | 25648 | 0.060 |
Why?
|
| Skull | 1 | 2006 | 249 | 0.060 |
Why?
|
| Radiography | 1 | 2006 | 813 | 0.060 |
Why?
|
| Phenotype | 1 | 2010 | 2378 | 0.060 |
Why?
|
| Heart Defects, Congenital | 1 | 2006 | 351 | 0.060 |
Why?
|
| Fever | 1 | 2004 | 125 | 0.060 |
Why?
|
| Middle Aged | 1 | 2021 | 25028 | 0.050 |
Why?
|
| Retinoids | 1 | 2022 | 17 | 0.050 |
Why?
|
| Eyebrows | 1 | 2022 | 10 | 0.050 |
Why?
|
| Anemia, Sickle Cell | 1 | 2004 | 131 | 0.050 |
Why?
|
| Critical Illness | 1 | 2004 | 294 | 0.050 |
Why?
|
| Photography | 1 | 2021 | 37 | 0.050 |
Why?
|
| Age of Onset | 1 | 2021 | 310 | 0.050 |
Why?
|
| Immunoglobulins, Intravenous | 2 | 2012 | 66 | 0.040 |
Why?
|
| Vitamin D | 1 | 2022 | 261 | 0.040 |
Why?
|
| DNA, Viral | 2 | 2008 | 265 | 0.040 |
Why?
|
| Genitalia | 1 | 2018 | 21 | 0.040 |
Why?
|
| Administration, Topical | 1 | 2018 | 95 | 0.040 |
Why?
|
| Anal Canal | 1 | 2018 | 89 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 1801 | 0.040 |
Why?
|
| Electroencephalography | 1 | 2021 | 709 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 1621 | 0.030 |
Why?
|
| Mothers | 1 | 2016 | 141 | 0.030 |
Why?
|
| Cloning, Molecular | 2 | 1990 | 646 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 927 | 0.030 |
Why?
|
| Genes, Viral | 2 | 1990 | 116 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2012 | 268 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 316 | 0.020 |
Why?
|
| Dermatologic Agents | 1 | 2012 | 71 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 376 | 0.020 |
Why?
|
| Viral Proteins | 2 | 1990 | 300 | 0.020 |
Why?
|
| Capsid | 1 | 1989 | 34 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 1990 | 151 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 3362 | 0.020 |
Why?
|
| Isoindoles | 1 | 2008 | 14 | 0.020 |
Why?
|
| Prognosis | 1 | 2016 | 3679 | 0.020 |
Why?
|
| Plasma | 1 | 2008 | 50 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2012 | 971 | 0.020 |
Why?
|
| Organophosphonates | 1 | 2008 | 50 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2008 | 154 | 0.020 |
Why?
|
| Family Health | 1 | 2008 | 162 | 0.020 |
Why?
|
| Eye Abnormalities | 1 | 2007 | 41 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2007 | 173 | 0.020 |
Why?
|
| Cytosine | 1 | 2008 | 127 | 0.020 |
Why?
|
| Benzamides | 1 | 2008 | 229 | 0.020 |
Why?
|
| Skin Transplantation | 1 | 2008 | 172 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2008 | 293 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2012 | 977 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 456 | 0.020 |
Why?
|
| Developmental Disabilities | 1 | 2007 | 195 | 0.020 |
Why?
|
| Incidence | 1 | 2007 | 1577 | 0.010 |
Why?
|
| Neurons | 1 | 1990 | 1546 | 0.010 |
Why?
|
| Molecular Sequence Data | 3 | 1990 | 3030 | 0.010 |
Why?
|
| Brain | 1 | 2007 | 2216 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1990 | 2062 | 0.010 |
Why?
|
| Base Sequence | 2 | 1989 | 2330 | 0.010 |
Why?
|
| DNA | 2 | 1990 | 1294 | 0.010 |
Why?
|
| Mice | 3 | 1990 | 11352 | 0.010 |
Why?
|
| Viral Structural Proteins | 1 | 1990 | 19 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 1990 | 148 | 0.010 |
Why?
|
| Capsid Proteins | 1 | 1989 | 32 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1989 | 157 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 1989 | 77 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 1990 | 114 | 0.010 |
Why?
|
| Enterovirus Infections | 1 | 1989 | 41 | 0.010 |
Why?
|
| Plasmids | 1 | 1989 | 287 | 0.010 |
Why?
|
| Epitopes | 1 | 1989 | 255 | 0.010 |
Why?
|
| Virulence | 1 | 1989 | 271 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 1990 | 526 | 0.010 |
Why?
|
| Picornaviridae | 1 | 1988 | 8 | 0.010 |
Why?
|
| Spinal Cord | 1 | 1989 | 249 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1989 | 439 | 0.000 |
Why?
|
| Recombination, Genetic | 1 | 1990 | 439 | 0.000 |
Why?
|
| Transfection | 1 | 1989 | 896 | 0.000 |
Why?
|
| RNA, Viral | 1 | 1988 | 327 | 0.000 |
Why?
|
| Protein Biosynthesis | 1 | 1988 | 378 | 0.000 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1988 | 371 | 0.000 |
Why?
|
| Transcription, Genetic | 1 | 1989 | 1135 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1989 | 1376 | 0.000 |
Why?
|